Your browser doesn't support javascript.
loading
Glucose metabolism links astroglial mitochondria to cannabinoid effects.
Jimenez-Blasco, Daniel; Busquets-Garcia, Arnau; Hebert-Chatelain, Etienne; Serrat, Roman; Vicente-Gutierrez, Carlos; Ioannidou, Christina; Gómez-Sotres, Paula; Lopez-Fabuel, Irene; Resch-Beusher, Monica; Resel, Eva; Arnouil, Dorian; Saraswat, Dave; Varilh, Marjorie; Cannich, Astrid; Julio-Kalajzic, Francisca; Bonilla-Del Río, Itziar; Almeida, Angeles; Puente, Nagore; Achicallende, Svein; Lopez-Rodriguez, Maria-Luz; Jollé, Charlotte; Déglon, Nicole; Pellerin, Luc; Josephine, Charlène; Bonvento, Gilles; Panatier, Aude; Lutz, Beat; Piazza, Pier-Vincenzo; Guzmán, Manuel; Bellocchio, Luigi; Bouzier-Sore, Anne-Karine; Grandes, Pedro; Bolaños, Juan P; Marsicano, Giovanni.
Afiliação
  • Jimenez-Blasco D; Institute of Functional Biology and Genomics, University of Salamanca, CSIC, Salamanca, Spain.
  • Busquets-Garcia A; Centro de Investigación Biomédica en Red sobre Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.
  • Hebert-Chatelain E; Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, University of Salamanca, CSIC, Salamanca, Spain.
  • Serrat R; INSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
  • Vicente-Gutierrez C; University of Bordeaux, Bordeaux, France.
  • Ioannidou C; Integrative Pharmacology and Systems Neuroscience, IMIM Hospital del Mar Medical Research Institute, Barcelona, Spain.
  • Gómez-Sotres P; Canada Research Chair in Mitochondrial Signaling and Physiopathology, Université de Moncton, Moncton, New Brunswick, Canada.
  • Lopez-Fabuel I; Department of Biology, Université de Moncton, Moncton, New Brunswick, Canada.
  • Resch-Beusher M; INSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
  • Resel E; University of Bordeaux, Bordeaux, France.
  • Arnouil D; Institute of Functional Biology and Genomics, University of Salamanca, CSIC, Salamanca, Spain.
  • Saraswat D; Centro de Investigación Biomédica en Red sobre Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.
  • Varilh M; Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, University of Salamanca, CSIC, Salamanca, Spain.
  • Cannich A; INSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
  • Julio-Kalajzic F; University of Bordeaux, Bordeaux, France.
  • Bonilla-Del Río I; INSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
  • Almeida A; University of Bordeaux, Bordeaux, France.
  • Puente N; Institute of Functional Biology and Genomics, University of Salamanca, CSIC, Salamanca, Spain.
  • Achicallende S; Centro de Investigación Biomédica en Red sobre Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.
  • Lopez-Rodriguez ML; Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, University of Salamanca, CSIC, Salamanca, Spain.
  • Jollé C; Institute of Functional Biology and Genomics, University of Salamanca, CSIC, Salamanca, Spain.
  • Déglon N; Centro de Investigación Biomédica en Red sobre Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.
  • Pellerin L; Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, University of Salamanca, CSIC, Salamanca, Spain.
  • Josephine C; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Instituto Universitario de Investigación Neuroquímica (IUIN) and Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.
  • Bonvento G; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Panatier A; INSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
  • Lutz B; University of Bordeaux, Bordeaux, France.
  • Piazza PV; INSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
  • Guzmán M; University of Bordeaux, Bordeaux, France.
  • Bellocchio L; INSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
  • Bouzier-Sore AK; University of Bordeaux, Bordeaux, France.
  • Grandes P; INSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
  • Bolaños JP; University of Bordeaux, Bordeaux, France.
  • Marsicano G; INSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Nature ; 583(7817): 603-608, 2020 07.
Article em En | MEDLINE | ID: mdl-32641832
ABSTRACT
Astrocytes take up glucose from the bloodstream to provide energy to the brain, thereby allowing neuronal activity and behavioural responses1-5. By contrast, astrocytes are under neuronal control through specific neurotransmitter receptors5-7. However, whether the activation of astroglial receptors can directly regulate cellular glucose metabolism to eventually modulate behavioural responses is unclear. Here we show that activation of mouse astroglial type-1 cannabinoid receptors associated with mitochondrial membranes (mtCB1) hampers the metabolism of glucose and the production of lactate in the brain, resulting in altered neuronal functions and, in turn, impaired behavioural responses in social interaction assays. Specifically, activation of astroglial mtCB1 receptors reduces the phosphorylation of the mitochondrial complex I subunit NDUFS4, which decreases the stability and activity of complex I. This leads to a reduction in the generation of reactive oxygen species by astrocytes and affects the glycolytic production of lactate through the hypoxia-inducible factor 1 pathway, eventually resulting in neuronal redox stress and impairment of behavioural responses in social interaction assays. Genetic and pharmacological correction of each of these effects abolishes the effect of cannabinoid treatment on the observed behaviour. These findings suggest that mtCB1 receptor signalling can directly regulate astroglial glucose metabolism to fine-tune neuronal activity and behaviour in mice.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Astrócitos / Receptor CB1 de Canabinoide / Metabolismo Energético / Glucose / Mitocôndrias Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Astrócitos / Receptor CB1 de Canabinoide / Metabolismo Energético / Glucose / Mitocôndrias Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha